Results 221 to 230 of about 1,861,445 (361)

A NEW SCALING RELATION FOR H II REGIONS IN SPIRAL GALAXIES: UNVEILING THE TRUE NATURE OF THE MASS-METALLICITY RELATION [PDF]

open access: bronze, 2012
F. F. Rosales-Ortega   +7 more
openalex   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Antisense transcription can induce expression memory via stable promoter repression. [PDF]

open access: yesGenome Biol
Mutzel V   +9 more
europepmc   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

THE Paα LUMINOSITY FUNCTION OF H II REGIONS IN NEARBY GALAXIES FROMHST/NICMOS [PDF]

open access: bronze, 2013
Guilin Liu   +7 more
openalex   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

PNs and H II regions in NGC 300 [PDF]

open access: bronze, 2006
L. Rizzi, R. H. Méndez, W. Gieren
openalex   +1 more source

Home - About - Disclaimer - Privacy